Life-Threatening Radiation Necrosis After Complete Response to Pembrolizumab in a Patient With a Metastatic Silent PIT1 Pituitary Neuroendocrine Tumor (PitNET). [PDF]
De Alcubierre D +9 more
europepmc +1 more source
Determinant Factors of Self‐Care Deficit in People With Chronic Wounds: A Scoping Review
ABSTRACT Aims To identify and synthesise the scientific evidence on determinants of self‐care deficits in people with chronic wounds. Design Scoping review based on the Joanna Briggs Institute guidelines. Methods This scoping review was conducted by a review team responsible for study screening, data extraction and synthesis.
Janislei Soares Dantas +4 more
wiley +1 more source
Diagnostic Utility of T-PIT, PIT-1, and SF-1 in Differentiating Pituitary Neuroendocrine Tumors From Sinonasal and Skull Base Tumors. [PDF]
Elsafy H +6 more
europepmc +1 more source
Insomnia and Risk of Tooth Wear and Fracture: Evidence From a Nationwide Population‐Based Cohort
In this nationwide population‐based cohort study, insomnia was associated with increased risks of tooth wear and tooth fracture. These findings suggest that insomnia may have clinically relevant implications for oral health. ABSTRACT Background Insomnia is associated with various systemic conditions; however, its relationship with structural dental ...
Heon‐Young Kim +8 more
wiley +1 more source
Sellar Lesions: Novel Aspects in Diagnosis and Management. [PDF]
Kostopoulos G +3 more
europepmc +1 more source
Paget's Disease of the Skull Associated with a Pituitary Neoplasm [PDF]
openaire +2 more sources
Selumetinib as a Target Therapy in Progressive Paediatric Low‐Grade Gliomas—Case Series (pLGG)
ABSTRACT Background Optic pathway gliomas (OPGs) occur in 15%–20% of children with neurofibromatosis type 1 (NF1). While smaller gliomas may be only monitored, the current standard of care for symptomatic ones relies on chemotherapy, most commonly carboplatin and vincristine.
Laura Trapani +12 more
wiley +1 more source
The Real-World Endocrine Toxicity Profile of ICIs, VEGFR-TKIs, and Their Combination: Analysis of the FDA Adverse Event Reporting System (FAERS) Database. [PDF]
Marrano N +12 more
europepmc +1 more source

